Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Freenome

Tracked across 2 events · 26 articles · First seen Jul 27, 2026 · Last active Aug 19, 2026

Sentiment
40
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 80
Regulatory
Impact: Freenome received its first FDA approval and a $100 million milestone payment from Abbott, boosting its commercial prospects and validating its technology.
Jul 27, 2026 · 6 articles
4 0
Tech
A large U.S. study published in the journal Gastro Hep Advances found that daily consumption of sugar-sweetened beverages is associated with a more than doubled risk of stomach (gastric) cancer. Researchers from the Mass General…
Impact: Provided grant support to Andrew T. Chan; no direct impact.
Aug 17, 2026 · 20 articles
ERGEN INTELLIGENCE
Track Freenome live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.